Pricer vs StrongPoint

Nomination committee appointed ahead of 2027 Annual General Meeting of Pricer AB

In accordance with the decision at the Annual General Meeting on May 13, 2026, Pricer’s Chairman of the Board Bernt Ingman has contacted the company’s three largest shareholders to form a Nomination Committee.

Pricer to showcase the shelf edge as a driver of grocery retail performance at Groceryshop 2026

At Groceryshop 2026 in Las Vegas, Pricer will demonstrate how digital shelf-edge technology can help grocery retailers strengthen promotional execution, improve store operations and create more engaging shopping experiences, with Pricer Avenue™ delivering up to 4.8% sales uplift in a recent live-store study.

Pricer Showcases High-Impact Retail Solutions and In-Store Sales Uplift Data at NRF Europe 2026

At NRF Europe in Paris, Pricer will highlight Pricer Avenue™, displaying real-world store data showing up to +4.8% sales uplift, alongside its connected store ecosystem and a joint session on sustainable automation.

10-Q Financial Filing Analysis for StrongPoint

Sutro Biopharma, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing the financial impacts of its ongoing corporate transition and pipeline reorientation. Total revenue decreased 85% year-over-year to $9.8 million from $63.7 million in Q2 2025, primarily driven by the termination of the STRO-003 collaboration with Ipsen and the resulting derecognition of deferred revenue. The company posted a net loss of $38.5 million for the quarter, mitigated in part by lower operating expenses following a two-thirds workforce reduction in 2025 and an externalized CDMO manufacturing model. Liquidity was bolstered earlier in the year via an underwritten public offering generating $110.0 million in gross proceeds to advance clinical assets STRO-004 and STRO-006, alongside a $10.0 million clinical milestone achieved from partner Astellas.

• Q2 2026 revenue fell 85% year-over-year to $9.8 million (down from $63.7 million in Q2 2025) due to the termination of the Ipsen collaboration, resulting in a net loss of $38.5 million.
• The company secured $110.0 million in gross proceeds via an underwritten public offering in February 2026 and recognized a $10.0 million Phase 1 clinical milestone from partner Astellas.
• Operating structure reflects major 2025 cost-reduction initiatives, including a two-thirds workforce reduction and a transition to an outsourced CDMO manufacturing model.

Investor Presentation Released: StrongPoint

AI parsed presentation narrative: StrongPoint is navigating a short-term revenue decline in its Nordic markets due to a transition between Electronic Shelf Label (ESL) partners while experiencing significant growth in its International segment. Management is focused on right-sizing the cost base and leveraging a recent breakthrough into the US market with their Order Picking solution to drive long-term, high-margin growth. Key tailwinds mentioned: US Market Breakthrough, Vusion Partnership Transition.

American Grocery Retailer Meijer Inc Chooses StrongPoint for E-Commerce Order Picking

American Grocery Retailer Meijer Inc Chooses StrongPoint for E-Commerce Order Picking